RecruitingNCT02806388

Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project

Sponsor

National Cancer Centre, Singapore

Enrollment

5,500 participants

Start Date

Oct 1, 2011

Study Type

OBSERVATIONAL

Conditions

Solid Tumor

Summary

This study aims to screen tumor molecular profile for better selection of anticancer treatment, in particular, allocation to clinical trials if available.

Eligibility

Min Age: 12 Years

Inclusion Criteria5

Confirmed histological diagnosis of solid tumor
Suitable for systematic treatment and clinical trials
ECOG (Eastern cooperative oncology group) performance status < 2
Able to provide tumor tissue for molecular profiling
Able to understand and sign the informed consent form

Exclusion Criteria1

None

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

National Cancer Centre, Singapore

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02806388

Related Trials

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

NCT037398273 locations

NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors

NCT074893781 location